Infectious Disease
COVID-19 mRNA Vaccination in the Pharmacy: Discussing the Most Recent Guidance on Vaccination in Children & Adolescents and Booster Vaccinations
Community pharmacists have played a pivotal role in vaccinating Canadians during the COVID-19 pandemic. With guidance around COVID-19 vaccination evolving over time, this program aims to address questions that pharmacists may currently face in clinical practice: should we vaccinate individuals who have already have COVID? If so, when? Who is eligible for a first booster dose? Who is eligible for a second booster dose? Should adolescents receive booster vaccination?
The overall goal of the program is to increase pharmacists’ confidence in discussing COVID-19 vaccination with their patients and vaccinating eligible patients.
DURATION
30 min
PROFESSION
Pharmacy
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-09-15
Community pharmacists have played a pivotal role in vaccinating Canadians during the COVID-19 pandemic. With guidance around COVID-19 vaccination evolving over time, this program aims to address questions that pharmacists may currently face in clinical practice: should we vaccinate individuals who have already have COVID? If so, when? Who is eligible for a first booster dose? Who is eligible for a second booster dose? Should adolescents receive booster vaccination?
The overall goal of the program is to increase pharmacists’ confidence in discussing COVID-19 vaccination with their patients and vaccinating eligible patients.
This learning activity is supported by Pfizer Canada through an unrestricted educational grant and may contain content that is not consistent with the approved Pfizer Canadian Product Monograph.
Faculty
Earl Rubin, MD, FRCPC, PID
Cora Constantinescu, BSc, MD, FRCPC, PID
Renée-Claude Duval, MD, FRCPC, PID
Carlene Oleksyn, BSP RPH CTH
Carole Dion, BScPharm
James Kim, MD, MBBCh, PgDip, FCFP
Christine Palmay, MD, CCFP, FCFP
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Discuss why COVID-19 vaccination remains essential in children and adolescents.
- Describe the NACI recommendations for COVID-19 vaccination in children and adolescents.
- Identify patients who are eligible for first booster and second booster doses of COVID-19 vaccines.
- Start a conversation with eligible patients regarding booster vaccinations.